LOL - it's amusing watching pumpers grasping for straws with this kind of pathetic excuse (This comment is not directed to legit buyers who actually got burned buying TRXC).
So, basically you're saying that the shorts orchestrated the whole plan for the FDA to deny approval? WOW...this is why poorly educated investors stay poorly educated (and $ poor) because they can't admit the reality of the situation and learn from it.
Hmmm...April 19th - "I work this business, FDA approval is a lock, whether it is this week or next month or the month after that, do yourselves a favor and don't sit on the edge of your seats waiting and watching minute by minute, this is not a football game after all."
You were saying? How is it a "lock" when they aren't really pursuing it anymore? Or, does lock mean 5 years from now?
"the Surgibot was not only equal to the Spyder, but offered much more"
100 times 0 is still 0.
I have no position in this stock but I do keep my eye on the competition? The problem for the foreseeable future is that there is not going to be one iota of good news coming forth for several quarters (if any). Recently, this stock has been propped up by "hopes and dreams" and unfortunately, after tomorrow's dump, it will slowly whither away in price.
I'm not trying to dump on the longs caught up in this - just stating the reality.
You might want to recall how Randolph and Mortimer started out and then finished...
Your pinning your hopes on Alf - which already has a telling track record (it's never gotten traction)? How is going through the hoops and costs of obtaining its FDA approval going to improve anything but more cash burn?
You can direct your anger at the MB "trolls" but they can't be worse than the MB pumpers who have repeated stated that they were going to obtain (locked in) FDA approval and you should "buy, buy, buy' or "I'm buying more at these prices", etc. The trolls didn't cause this - mismanagement and your own "belief" did. Learn from it and be more cautious in the future...
"Really just giving back a few days gains."
LOL. But what news is going to keep it from sliding more - they can't conjure up something (good news) for several more quarters. The anticipated approval was all they were hanging on - price wise.
Ouch. "first alf-x deal"? You really think that if they sell one machine that will "pop the cherry"? I've seen ISRG lose millions in market cap because they sold **one less** machine than expected - and they had sold over a 100 machines that particular quarter.
"Not many companies gain acceptance from the FDA on their first approach."
You might actually want to perform some research before stating "facts".such as this. The vast majority actually do.
" I am somewhat optimistic about ALF-X because it already has CE Mark in Europe and substantial surgical performance clinical data,.."
As bad as this sounds, I think you need to Google the WhiteDiamond report on TRXC. I'm not a fan of these type of hit pieces but I have to say that the guy seems to have hit the nail on the head in regards to his "analysis" of TRXC. Pay particular attention to the mentions of the ALF-X system and where he states there was not a single ALF-X sold in 2013, 2014, or 2015.
"...but uncharted territory in the field of science on the human body. "
How is this "uncharted territory" when ISRG has been doing this for over a decade?
"We have the Nina, the Pinta and the Sugibot Maria.."
Looking at history, TRXC owns the Costa Concordia, Edmund Fitzgerald, and the Titanic...
"and the 510k application for surgibot wasnt the proper application to be sending in."
If that's true doesn't it concern you that the company's management is not competent enough to figure out which application to submit?
"Sorry, I'm not quite sure which application it would be to qualify as an original product instead of a sufficiently equivalent one"
Now YOU sound like management material to me...
"Wow, now ain't that something?"
I'm not sure you realized what you just posted. It's a sad situation for TRXC if ISRG can simply pull out their oldest technology, which is sitting in the back warehouse, and still beat the ALF-X.
"...why does Intuitive have to throw 7 year old recycled tech at the market?"
ISRG has always been refurbishing and selling their older equipment - mostly to low-end hospitals that can't afford the newer state-of-the-art systems.
Also, ISRG has not "pulled their top of the line from the market" as you stated. Rather, they are selling systems that match the lower price-point the low-end hospitals have indicated they are willing to pay.
"They said that ISRG is throwing old junk at the market at really cheap prices to try and make the sales"
Well, I guess that statement just means that the ISRG "junk" competes with TRXC's ALF-X.
I'm not sure what you think I'm making up. Rather, I'm refuting your made up statement about ISRG pulling their "top of the line " systems from the market. I'm not sure why he was surprised but what Pope failed to understand is that ISRG probably has an army of older refurbished da Vinci's to throw at ALF-X's market (the low end) whenever needed.
ISRG can always low ball TRXC in any particular good-sized account deal that presents itself as a threat. However, they only have to keep that up for roughly a year or less until TRXC runs out of cash.
Good luck to you as well.
" So you think ISRG strategy will be to drive TRXC out of biz, by undercutting them the whole way?"
Absolutely. And as much as possible, ISRG is not going to let TRXC gain any traction - especially now that they are on the ropes with the FDA disapproval and burning more cash with little to no income.
"Gee somewhere I think there is a law about that. I think that might be called a "Monopoly"
I'm surmising that ISRG is substituting their older systems for this very reason. If they were to offer their high-end systems at heavily discounted prices, they may be accused of that very thing.
"In fact it is about 60-70% cheaper to use per procedure."
Being cheaper is not the only consideration. First of all, they need to consider the viability of the company. No hospital (administrator) l wants to be stranded with a expensive piece of equipment that they can no longer have serviced because the vendor is defunct. Also, ISRG has set the standard and most buyers will want to stay with the industry standard because that's what the experience robotic surgeons currently know and it helps their recruiting efforts. Finally, despite the "advantages" that you mention, there are considerably more advantages going in favor of the da Vinci and, besides their patents, they have exclusive rights to attractive third party technology that is locked in for years to come.
"Don't you wish you bought ISRG at 2 bucks?"
Although it may not be 2 bucks, there will be ample opportunity for me buy in the future if they prove to be a viable company - just as there was when I bought ISRG after they proved themselves.